Page last updated: 2024-09-04

terephthalamidine and triaziquone

terephthalamidine has been researched along with triaziquone in 1 studies

*Triaziquone: Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys. [MeSH]

*Triaziquone: Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys. [MeSH]

Compound Research Comparison

Studies
(terephthalamidine)
Trials
(terephthalamidine)
Recent Studies (post-2010)
(terephthalamidine)
Studies
(triaziquone)
Trials
(triaziquone)
Recent Studies (post-2010) (triaziquone)
111151270

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hines, JW; Voyksner, RD; Williams, FP1

Other Studies

1 other study(ies) available for terephthalamidine and triaziquone

ArticleYear
Analysis of candidate anticancer drugs by thermospray high-performance liquid chromatography-mass spectrometry and by high-resolution mass spectrometry.
    Journal of chromatography, 1985, Oct-25, Volume: 347, Issue:1

    Topics: 3-Deazauridine; Antineoplastic Agents; Chromatography, High Pressure Liquid; Indoles; Isoindoles; Mass Spectrometry; Phthalimides; Spectrophotometry, Ultraviolet; Triaziquone

1985